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The earliest progenitor in the hierarchy of hematolymphopoietic cells, the hematopoietic stem cell (HSC), can repopulate the bone marrow after transplantation and sustain hematopoiesis, generating all known mature blood cells. Assay systems to measure repopulating capacity of HSCs in humans are not available. However, early progenitors can be detected by their ability to produce cobble stone areas (CAFC), and colony-forming cells (CFC) for at least 5 weeks on stroma (LTC-IC). In addition, the repopulating capacity of human HSCs can be measured in mice with severe combined immunodeficiency (SRC).
Several surface antigens such as CD34, CD38, and HLA DR have been used as markers to enrich HSC from different sources. 1 However, even the most highly enriched populations still remain heterogeneous. A more than 1000-fold enrichment of SRC and LTC-IC was found in CD34
+

CD38
− cells compared with unseparated mononuclear cells from cord blood or bone marrow.
2,3 Here, we studied whether after ex vivo culture CD38 still remains a marker for more differentiated progenitor cells.
Cord blood CD34 + hematopoietic progenitor cells were purified by the MACS progenitor isolation kit (Miltenyi Biotec, Bergish Gladbach, Germany) and cultured for 4 days. The effect of two different growth factor combinations on the expression of CD34 and CD38 was analyzed. Cells were either cultured in BIT medium supplemented with Flt-3 ligand (FL, 100 ng/ml), stem cell factor (SCF, 100 ng/ml), and interleukin-3 (IL-3, 20 ng/ml, or with IL-1␤ (3 ng/ml), SCF (10 ng/ml), and Il-3 (20 ng/ml, cytokines were obtained from TeBu, Frankfurt a.M., Germany). These conditions were previously shown to expand LTC-IC and CD34 + cells, respectively. We then determined whether the initial staining of cells for FACS sorting with anti-CD38 directly after isolation interfered with CD38 antigen detection on day 4. Directly after MACS purification, half the cells were stained with anti-CD38 conjugated with fluorescein and then cultured for 4 days with FL, IL-3 and SCF. The remaining cells were cultured directly as a control. On day 4, both populations (prestained and directly cultured) were stained with anti-CD38 cychrome and analyzed by flow cytometry. No difference in the intensity of anti-CD38 staining was seen (data not shown).
Finally, we tested whether the CD34 + CD38 − cells that arose after culture were enriched for cells of specific lineages. CD34 +
+ cells were sorted, cultured for 4 days and then stained with CD34, CD38, and with antibodies against specific lineage antigens. The results of the three-color flow cytometric analysis are shown in Table 1 . On CD34 + CD38 − cells no significant staining was seen with antibodies against B cell, T cell, or dendritic markers. A low percentage expressed Glycophorin-A and myeloid antigens (CD33, CD14, CD16) were found on approximately half of the day 4 CD34 +
− cells. These results show that although within the CD34 +
− cells there is a population with myeloid potential, a considerable number of cells is negative for standard lineage markers.
In conclusion, the CD34 + CD38 − Lin − cells that arose from a CD34 + CD38 + population during culture have a phenotype normally found on early hematopoietic progenitors directly after isolation. However, functional studies, such as LTC-IC and SRC assays will be necessary to clarify whether this population is indeed enriched in HSC, or whether the CD38 antigen is not a reliable indicator of differentiation after ex vivo culture. 
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